Considerations for use of Real-World Evidence in oncology: lessons learned from Friends of Cancer Research collaborations Published October 2020 Citation Baxi, SS, Cohen, AB, Mahoney, N, Rasmussen, E, Tymejczyk, O, Torres, AZ. . Friends of Cancer Research. . https://friendsofcancerresearch.org/sites/default/files/2020-10/Use_of_Real-World_Evidence_in_Oncology-2020.pdf Authors:Baxi, SS, Cohen, AB, Mahoney, N, Rasmussen, E, Tymejczyk, O, Torres, AZ Sources:Friends of Cancer Research Share Posted inPublicationsMethodologyNon-small cell lung cancer More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerJAMA Network OpenMay 2024Response- and progression-based endpoints in trial and observational cohorts of patients With NSCLCLu Y, Langerman SS, McCain E, et al. Publication summaryPublicationsMethodologyNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Disease burden and rwPFS as a surrogate endpoint for rwOS in NTRK+ NSCLC and other advanced/metastatic solid tumorFlores Avile C, Su I-H, Huang P-C, Cho-Phan C, Camidge R, Yuan Y.Publication summaryPublicationsNon-small cell lung cancer